Table 4.
Unadjusted analysis of percentage survival (±SE) from colorectal cancer by time from diagnosis (days) to commencement of specified treatment: South Australian major public hospitals, diagnoses 2000–2010*
| Specified treatment | Time (days) | Numbers of cases | Follow-up time from diagnosis (years) | |||||
| 1 | 2 | 3 | 4 | 5 | 10 | |||
| Surgical treatment (surgery cases) |
<30 | 988 | 85.4±1.2 | 78.2±1.5 | 72.9±1.5 | 69.8±1.6 | 67.5±1.7 | 63.3±2.0 |
| 31–60 | 355 | 93.1±1.6 | 89.9±1.9 | 84.7±2.2 | 81.9±2.4 | 79.7±2.5 | 75.9±2.9 | |
| 61–90 | 100 | 92.9±3.7 | 84.1±4.6 | 77.5±5.3 | 74.6±5.5 | 72.6±5.8 | 57.7±9.0 | |
| >90 | 232 | 92.6±2.2 | 82.4±2.9 | 73.9±3.2 | 67.4±3.5 | 67.8±3.7 | 50.4±5.0 | |
| Radiotherapy (radiotherapy cases) |
<30 | 129 | 82.0±4.0 | 70.0±4.5 | 62.4±4.7 | 58.0±4.7 | 53.1±4.8 | 44.4±5.5 |
| 31–60 | 233 | 87.0±2.6 | 77.8±3.0 | 68.2±3.4 | 64.4±3.5 | 61.3±3.6 | 55.2±4.4 | |
| 61–90 | 107 | 95.3±3.2 | 87.5±4.1 | 79.4±4.7 | 73.8±5.1 | 64.8±5.5 | 49.0±6.9 | |
| >90 | 147 | 87.6±3.3 | 62.6±4.3 | 53.1±4.4 | 42.8±4.3 | 39.2±4.3 | 27.3±4.3 | |
| Chemotherapy (chemotherapy cases) |
<30 | 238 | 68.0±3.3 | 52.8±3.4 | 43.4±3.3 | 40.7±3.3 | 38.4±3.3 | 33.1±3.4 |
| 31–60 | 633 | 87.2±3.4 | 73.8±1.8 | 67.9±2.0 | 62.8±2.0 | 59.4±2.1 | 49.5±2.5 | |
| 61–90 | 382 | 92.3±1.6 | 78.8±2.3 | 68.9±2.6 | 64.5±2.7 | 59.8±2.8 | 56.1±3.0 | |
| >90 | 303 | 94.4±1.7 | 78.1±2.6 | 68.6±2.9 | 63.2±3.0 | 56.8±3.1 | 45.1±3.9 | |
| Any treatment (surgiery cases) |
<30 | 1030 | 85.5±1.1 | 78.1±1.3 | 72.6±1.4 | 69.4±1.5 | 67.2±1.6 | 63.1±1.8 |
| 31–60 | 428 | 93.4±1.2 | 88.8±1.5 | 83.8±1.8 | 80.5±2.0 | 78.0±2.2 | 71.5±2.9 | |
| 61–90 | 118 | 94.0±2.2 | 85.9±3.3 | 79.6±3.9 | 74.8±4.4 | 71.7±4.7 | 56.6±7.8 | |
| >90 | 99 | 91.7±2.8 | 82.2±3.9 | 71.9±4.7 | 63.9±5.2 | 57.1±5.6 | 43.8±8.2 | |
*Kaplan-Meier product-limit estimate; date of censoring of live cases: 31 December 2012.